Welcome to the InfoSci Platform
Institutions as Enablers of Science-Based Industries: The Case of Biotechnology in Mexico

Institutions as Enablers of Science-Based Industries: The Case of Biotechnology in Mexico

Marcia Villasana
Copyright: © 2020 |Pages: 28
ISBN13: 9781522592730|ISBN10: 1522592733|EISBN13: 9781522592747
DOI: 10.4018/978-1-5225-9273-0.ch082
Cite Chapter Cite Chapter

MLA

Villasana, Marcia. "Institutions as Enablers of Science-Based Industries: The Case of Biotechnology in Mexico." Disruptive Technology: Concepts, Methodologies, Tools, and Applications, edited by Information Resources Management Association, IGI Global, 2020, pp. 1737-1764. https://doi.org/10.4018/978-1-5225-9273-0.ch082

APA

Villasana, M. (2020). Institutions as Enablers of Science-Based Industries: The Case of Biotechnology in Mexico. In I. Management Association (Ed.), Disruptive Technology: Concepts, Methodologies, Tools, and Applications (pp. 1737-1764). IGI Global. https://doi.org/10.4018/978-1-5225-9273-0.ch082

Chicago

Villasana, Marcia. "Institutions as Enablers of Science-Based Industries: The Case of Biotechnology in Mexico." In Disruptive Technology: Concepts, Methodologies, Tools, and Applications, edited by Information Resources Management Association, 1737-1764. Hershey, PA: IGI Global, 2020. https://doi.org/10.4018/978-1-5225-9273-0.ch082

Export Reference

Mendeley
Favorite

Abstract

Biotechnology impacts across different industrial uses of the life sciences, and has acquired a relevant role in addressing challenges faced by world economies such as those related to food, water, energy and healthcare provision. Many governments in emerging economies looking to exploit some of the opportunities provided by advances in biotechnology design institutional frameworks to cope and develop this complex science-based industry. In this context, a country´s science, technology and innovation institutional structure plays a key role in shaping the outcomes, commercialization, investments, and alliance strategies of this particular industry. This chapter builds on the innovation systems perspective to describe how institutions act as enabling factors for innovation and research in biotechnology. These factors are, as defined by the Biotechnology Industry Organization, infrastructure for R&D, human capital, intellectual property protection, regulatory environment, technology transfer frameworks, market, and commercial incentives.

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.